Skip to main content

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in ANIK — Anika Therapeutics, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in ANIK

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,658,785
+$637,271 QoQ
Shares Held
114,399
+7.6% QoQ
Ownership
0.860%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,628,257,886 across 43 Drug Manufacturers - Specialty & Generic names. ANIK ranks #38 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ANIK

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,658,785 114,399
2025-12-31 $1,021,514 106,297
2025-09-30 $976,378 103,870
2025-06-30 $1,407,637 133,047
2025-03-31 $2,253,523 149,935
2024-12-31 $2,262,624 137,462
2024-09-30 $3,703,913 149,956
2024-06-30 $3,803,147 150,144
2024-03-31 $3,717,747 146,368
2023-12-31 $2,677,437 118,157
2023-09-30 $2,116,572 113,611
2023-06-30 $2,916,229 112,249
2023-03-31 $3,173,531 110,499
2022-12-31 $3,290,306 111,159
2022-09-30 $2,594,366 109,007
2022-06-30 $2,322,887 104,072
2022-03-31 $2,615,206 104,150
2021-12-31 $3,639,253 101,570
2021-09-30 $4,322,606 101,565
2021-06-30 $4,313,761 99,648
2021-03-31 $4,836,347 118,567
2020-12-31 $5,139,318 113,551
2020-09-30 $4,014,323 113,431
2020-06-30 $4,291,712 113,748
2020-03-31 $3,340,203 115,538